OR-GUROBI-OPTIMIZATION
6.12.2022 15:02:17 CET | Business Wire | Press release
Gurobi Optimization, LLC, the leader in decision intelligence technology and creator of the world’s fastest mathematical optimization solver, recently announced the rebranding of its support team as “Gurobi Experts – Technical Advisory and Support Team.” This team of 15+ PhD-level optimization specialists is passionate about helping customers succeed with optimization and can provide comprehensive guidance on Gurobi products and mathematical optimization.
Matthias Miltenberger, Optimization Support Manager, explained that the reasoning behind the rebrand stemmed from some common misunderstandings about the word “support.”
“There’s this idea that ‘support’ means sitting in a call center all day with headphones on,” said Miltenberger. “Most people hear that word and think of experiences they’ve had calling up their phone or internet provider, which are often unpleasant experiences. And the assumption is that they’re not really talking to experts, so we definitely wanted to change that mindset.”
Indeed, the work of the Expert Team extends far beyond basic support. With over 150 years of optimization experience between them, the team works across three continents and uses their expert knowledge to provide a variety of services to customers around the world, including:
- Model troubleshooting: The Expert Team can help identify and troubleshoot unexpected problems, such as slow performance or code failure.
- Performance tuning: Rather than relying on a trial-and-error approach, the Expert Team often uses their expert knowledge to anticipate how the solver might react to certain parameter changes, which saves valuable time for customers.
- Outreach: On top of the virtual assistance they provide on a daily basis, they frequently attend conferences and events, where they teach attendees how to model problems, improve their models, and overcome many other common challenges. The team also shares their knowledge with Gurobi’s community forum, where customers can ask questions or share their own expertise.
“We’re people who care deeply about optimization and about helping our customers succeed,” explains Dr. Sonja Mars, who directs the team. “On any given day, you’ll see us digging deep into our customers’ complex installation questions, programming interfaces, performance tuning challenges, you name it.”
“In a nutshell, we help our customers get the most out of the Gurobi solver, which is a very complex and powerful product,” explained Miltenberger. “There’s the mathematical stuff, where you really need to understand what is happening inside the engine, but you also need to understand how to best use Gurobi on a variety of machine architectures.”
“Solving puzzles is what we do,” added Dr. Alison Cozad. “But what really excites me is working with customers. Understanding their problem, discussing with them, and then coming to a solution together—there’s nothing like it.”
Most customer communication with the Expert Team happens via email or a ticket system, which gives the team time to delve deep into an issue and find the best solution. However, the team is also available for video calls or screen-sharing sessions for issues that require more hands-on assistance. The team’s median first-reply time is just 27 minutes.
“We all love what we do,” explains Dr. Eli Towle. “Solving the most complex problems on the planet—where millions of trillions of possible solutions exist—in a short amount of time . . . that’s an exciting job.”
Gurobi customers appreciate the team’s personalized service, as well as the fact that the team can dedicate extra time to find solutions to complicated challenges. This is evidenced by their 98.5% positive customer satisfaction rating, as well as customer testimonials.
In addition to offering top-notch support, the Expert Team is constantly on the lookout for opportunities to innovate. Miltenberger recalls a case where one customer’s problem actually led to the development of a brand-new tool.
“For one particular customer with certain time constraints, I needed to come up with a new way of tuning their models. I saw this as an opportunity to create a new tool that makes it easier to complete all kinds of tuning requests. In the end, this solution turned into a software package called GRBlogtools, which the Expert Team now uses daily to analyze dozens or even hundreds of log files, to see if tweaking a parameter makes a difference in terms of performance.”
Learn more about how the Gurobi Expert Team uses its expertise to help users have the most successful optimization experience possible.
About Gurobi Optimization
With Gurobi’s decision intelligence technology, you can make optimal business decisions in seconds. From workforce scheduling, portfolio management, and marketing optimization, to supply chain design, and everything in between, Gurobi identifies your optimal solution, out of trillions of possibilities.
As the leader in decision intelligence, Gurobi delivers easy-to-integrate, full-featured software and best-in-class support, with an industry-leading 98% customer satisfaction rating.
Founded in 2008, Gurobi has operations across the Americas, Europe, and Asia. Over 2,500 global customers across 40+ industries run on Gurobi, including SAP, Air France, and the National Football League, as well as half of the Fortune 10 and 70% of top global tech companies. For more information, please visit https://www.gurobi.com/ or call +1 713 871 9341.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005457/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
